Q&A chair by Prof Baurain (University Hospital St Luc, Brussels) and Prof Bechter (University Hospital Leuven).
Other videos:
- Efficacy and safety for unresectable or metastatic BRAFV600-mutated melanoma
- Q&A - Efficacy and safety for unresectable or metastatic BRAFV600-mutated melanoma
- Rechallenge
BE1802773684 - Friday, February 9, 2018